Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE1
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Patients Hospitalized With Acute Heart Failure With Reduced Ejection Fraction (HFrEF)
- Status
- UNKNOWN
- Phase
- N/A
Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm
- Status
- COMPLETED
- Phase
- NA
Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
- Status
- COMPLETED
- Phase
- N/A
Bioavailability of Apixaban Sprinkle Compared to Apixaban Capsules
- Status
- COMPLETED
- Phase
- PHASE1
Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
- Status
- COMPLETED
- Phase
- N/A
Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)
- Status
- WITHDRAWN
- Phase
- N/A
Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- N/A
Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE2
APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)
- Status
- TERMINATED
- Phase
- N/A
BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection
- Status
- TERMINATED
- Phase
- PHASE2
OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease
- Status
- COMPLETED
- Phase
- PHASE2